kotak-logo
Vaishali Pharma Share Price

Vaishali Pharma Share Price

7.75
+0.04 (0.52%)
NSE: VAISHALI | Trading | Small Cap| as on 20 Apr, 2026 • 03:29 PM IST

Vaishali Pharma Annualised Return

1 Year

-37.65%

3 Years

-19.06%

5 Years

15.03%

Vaishali Pharma Share Price Today


As of 21 Apr 2026, Vaishali Pharma share price is ₹7.8. The stock opened at ₹7.9 and had closed at ₹7.7 the previous day. During today’s trading session, Vaishali Pharma share price moved between ₹7.51 and ₹7.95, with an average price for the day of ₹7.73. Over the last 52 weeks, the stock has recorded a low of ₹4.75 and a high of ₹15.24. In terms of performance, Vaishali Pharma share price has declined by 24.2% over the past six months and has declined by 37.65% over the last year.

Vaishali Pharma Stock Performance

1W Return19.41
1Y Return-36.00
Today's Low7.51
Prev. Close7.71
Mkt Cap (Cr.)101.11
1M Return29.60
3Y Return-44.72
52-Week High15.24
Open7.88
PE Ratio-193.75
6M Return-24.46
Today's High7.95
52-Week Low4.75
Face Value2

Vaishali Pharma Company background

Founded in: 2008
Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name Vaishali Pharma Private Limited on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company.Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 + formulation brands marketed in multiple countries of which dossier is in CTD format along with itsrespective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Companys synergistic collaboration with WHOGMP manufacturing facilities is backed by an excellent rapport with clients.In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments Medical Devices Directive. In addition, the Company has also been recognized by Government of India as One Star Export House and holds a valid certificate for the same from the Director General of Foreign Trade in 2017. In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.
Read More
Vaishali Pharma SIP Return Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 4,48,787 in 5 years with a gain of 1,48,787 (+49.60%)

Vaishali Pharma Fundamental

Market Cap (in crs)

101.11

Face Value

2

Turnover (in lacs)

27.33

Key Metrics

Qtr Change %
49.15% Fall from 52W High
-16.1
Dividend yield 1yr %
0

Vaishali Pharma Result Highlights

  • Vaishali Pharma reported a 25.5% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.

  • Its expenses for the quarter were down by 27.3% QoQ and - - YoY.

  • The net profit increased 10.9% QoQ and - - YoY.

  • The earnings per share (EPS) of Vaishali Pharma stood at 0.1 during Q3 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Vaishali Pharma Technical Analysis

Moving Averages Analysis
7.75
Current Price
Bullish Moving Averages
12
Bearish Moving Averages
4
5 EMA
7.20
10 EMA
6.70
12 EMA
6.60
20 EMA
6.50
26 EMA
6.50
50 EMA
6.80
100 EMA
7.80
200 EMA
9.30
Delivery & Volume
Loading chart...

Day

67.60%

Week

71.40%

Month

65.90%

Delivery & Volume

7.74
Pivot
Resistance
First Resistance
7.96
Second Resistance
8.18
Third Resistance
8.40
Support
First Support
7.52
Second support
7.30
Third Support
7.08
Relative Strength Index
70.52
Money Flow Index
82.79
MACD
0.13
MACD Signal
-0.14
Average True Range
0.54
Average Directional Index
34.69
Rate of Change (21)
29.38
Rate of Change (125)
-27.91
Compare

Vaishali Pharma Shareholding Pattern

Promoter
31.6%
Public
68.4%

Vaishali Pharma share price in the past 1-year return was -36. The Vaishali Pharma share hit a 1-year low of Rs. 4.75 and a 1-year high of Rs. 15.24.

The market cap of Vaishali Pharma is Rs. 101.11 Cr. as of 20/4/2026.

The PE ratios of Vaishali Pharma is -193.75 as of 20/4/2026.

The PB ratios of Vaishali Pharma is 1.5 as of 20/4/2026

You can easily buy Vaishali Pharma shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Vaishali Pharma share price is ₹15.24 and ₹4.75 as of 20/4/2026.

Please be aware that Vaishali Pharma stock prices are subject to continuous fluctuations due to various factors.